Key result
DOACs match VKAs in safety and efficacy for preventing thromboembolism during electrical cardioversion.
Why the study?
Anticoagulant preparation regimens and the potential role of direct oral anticoagulants for elective electrical cardioversion in persistent atrial fibrillation required discussion and updating.
Do direct oral anticoagulants prevent thromboembolic complications safely in patients with atrial fibrillation undergoing electrical cardioversion?
Do direct oral anticoagulants prevent thromboembolic complications safely in patients with atrial fibrillation undergoing electrical cardioversion?
DOACs are a safe and effective alternative to VKAs for patients requiring electrical cardioversion, offering simpler preparation protocols such as early cardioversion with loading doses.
Supports DOAC use in cardioversion; leaves open need for prospective RCTs before practice change.
The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using direct oral anticoagulants for this purpose is discussed.
No takes yet. Share an insight, caveat, or question.
Воловченко et al. (2021) conducted a review in Atrial fibrillation. Direct oral anticoagulants vs. Vitamin K antagonists was evaluated. Direct oral anticoagulants provide a safe and effective alternative to vitamin K antagonists for preventing thromboembolic complications in patients undergoing electrical cardioversion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: